Insider Purchases: Inside the Buy
Tag: hub-insiders
Conagra (CAG): 9% Yield Bargain or Value Trap? 🥫📉
Conagra (CAG) is down big, insiders are buying, and the dividend is near 9%. Is this a deep-value opportunity—or a trap in disguise? 🥫
📈 Top 10 Insider Buys April 2026: CEOs Buying OSCR, NKE, LW & More
CEOs, directors, and 10% owners are writing real checks again. From Oscar Health’s massive $11.9M buy to Nike’s continued dip-buying, here are the most interesting insider moves of April 2026.
Nike (NKE) Stock: Insiders Keep Buying the Dip—Should You? 👟
Nike (NKE) has fallen sharply from its highs, but insider buying, strong brand equity, and improved valuation are turning heads. Is this the start of a comeback—or a trap?
CEO Bets $11.9M: Is Oscar Health (OSCR) About to Shock the Market? 🚀
Oscar Health (OSCR) is no longer just a flashy disruptor—it’s aiming for profitability. With CEO Mark Bertolini buying $11.9M in stock and revenue projected to hit $19B in 2026, this could be one of the most compelling turnaround plays in healthcare.
🛢️ HMH Stock: Insiders Buy Millions After IPO Dip — Opportunity or Trap? 📉📈
HMH just IPO’d… and insiders are already buying millions. From strong margins to a pivot into mining and geothermal, here’s why this overlooked energy stock is getting attention.
Top 10 Insider Buys April 2026: Where CEOs Are Investing Millions Now 📈
When CEOs, directors, and 10% owners buy millions of dollars of their own stock, it’s worth paying attention. Here are the top insider buys of April 2026—and why MGM, PANW, AHCO, and others stand out.
Phreesia (PHR): Profitable… Then Crushed — Why Insiders Are Loading Up
Phreesia just hit profitability—and got punished for it. With insiders loading up and institutions fully committed, is this a classic overreaction or a value trap? Let’s decode the dip.
IPX Stock: America’s Titanium Comeback—or a Costly Experiment? 🦾
IperionX is betting on a U.S. titanium comeback. With government backing and disruptive tech, the upside is huge—but so are the risks.
📈 CME Group Stock Analysis 2026: A Near-Monopoly at Record Highs
CME Group is the “house that always wins” in financial markets. A dominant, cash-generating business—but at current prices, patience may pay off.
PANW Stock Analysis 2026: Why CEO Nikesh Arora Just Bet $10M on Palo Alto Networks 🛡️
PANW is the “Microsoft of cybersecurity”—dominant, profitable, and growing fast. But with premium valuation and heavy institutional ownership, is now the right time to buy?
Quick links
Search
Privacy Policy
Refund Policy
Shipping Policy
Terms of Service
Contact us
About us
FUNanc!al distills the fun in finance and the finance in fun, makes news personal, and helps all reach happiness.
